Global Health Concerns: Acute Hunger, Ebola, Virus Outbreaks, and Pharmaceutical Updates
This article provides a summary of recent health-related news, including acute hunger in Sudan, a new Ebola outbreak in Congo, and virus concerns affecting imports. Notable pharmaceutical developments involve India's Alembic Pharmaceuticals, the use of antidepressants during pregnancy, and several clinical trials impacting various conditions like Alzheimer’s and muscular disorders.
A global hunger monitor reports that about 19.5 million people in Sudan, or more than 40% of the population, are battling acute hunger amid the ongoing war, which has led to economic devastation and agricultural collapse.
In Africa, the Democratic Republic of Congo faces a new Ebola outbreak in its Ituri province, with 65 deaths reported from 246 suspected cases. The Africa CDC is collaborating with neighboring countries and international partners for a strategic response.
India's Alembic Pharmaceuticals posted a significant profit increase in its latest quarter, driven by robust U.S. demand for generic drugs. Meanwhile, new research finds no autism link to prenatal antidepressant use, challenging prior claims by public figures.
(With inputs from agencies.)
- READ MORE ON:
- health
- Sudan
- Ebola
- Congo
- pharmaceuticals
- Alembic
- hunger
- outbreak
- antidepressant
- pregnancy
ALSO READ
Alembic Pharmaceuticals Posts 29% Profit Surge in Q4
Health Highlights: From Sudan Hunger Crisis to Drug Approvals and Public Safety
Global Health Challenges: From Sudan's Hunger Crisis to FDA's Latest Approvals
Global Health Shifts: Hunger, Drugs, and Legal Battles
Sudan's Crisis: The War-Driven Hunger Catastrophe
Google News